Experience With Combination of Nimotuzumab and Intensity-Modulated Radiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s93238
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited